AXSM — Axsome Therapeutics Share News
0.000.00%
Last trade - 00:00- $7.51bn
- $7.40bn
- $638.50m
Axsome Therapeutics Q3 revenue rises on Auvelity and Sunosi
US RESEARCH ROUNDUP-Apple, Kaiser Aluminum, Reliance
Axsome Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Axsome Therapeutics Q2 revenue rises on AUVELITY growth
Brief: Axsome Therapeutics Q2 Net Income USD -51.314 Million
U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway
U.S. STOCKS ON THE MOVE-Ollie's Bargain Outlet Holdings, Steel Dynamics
Axsome Therapeutics rises after co resolves patent litigation for sleep disorder drug
Brief: Axsome Therapeutics Announces Settlement Resolving All Sunosi® (Solriamfetol) Patent Litigation
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi
Axsome Therapeutics Q1 revenue rises 57%, but loss widens on rising costs
U.S. RESEARCH ROUNDUP- Alphabet, Colgate-Palmolive, Welltower
U.S. RESEARCH ROUNDUP- Caterpillar, Textron, Wesco International
NASDAQ RESUMED AT 02:40 PM
US FDA approves Axsome's drug for Alzheimer's-related agitation (updated)
US FDA approves Axsome's drug for Alzheimer's-related agitation
NASDAQ TRADE HALT HALT NEWS PENDING AT 02:03 PM